An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients
Abstract Despite several studies designed to evaluate the efficacy of chloroquine and hydroxychloroquine in the treatment of coronavirus disease 2019 (COVID-19), there is still doubt about the effects of these drugs, especially in patients with severe forms of the disease. This randomized, open-labe...
Saved in:
Main Authors: | Álvaro Réa-Neto, Rafaella Stradiotto Bernardelli, Bruna Martins Dzivielevski Câmara, Fernanda Baeumle Reese, Marcos Vinicius Oliveira Queiroga, Mirella Cristine Oliveira |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/742e3a26f9dc40ebb2238b26cf944242 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
by: Jarir At Thobari
Published: (2021) -
Chloroquine/Hydroxychloroquine Use and Suicide Risk: Hypotheses for Confluent Etiopathogenetic Mechanisms?
by: Alessandra Costanza, et al.
Published: (2021) -
Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
by: Kavous Shahsavarinia, et al.
Published: (2021) -
Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study
by: Farrell DF
Published: (2012) -
Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
by: Tangtavorn N, et al.
Published: (2016)